Results Presentation from Article 📊

Created using ChatSlide

This study explores the therapeutic potential of crisdesalazine in treating multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). Findings indicate significant symptom alleviation and neuroprotection through the inhibition of mPGES-1, which facilitates a shift from inflammatory M1 to protective M2 macrophages and activates regulatory T cells (Tregs). The methodology includes EAE models, histology of spinal cords, and immunological studies. Results suggest promising...